♥

TTK Healthcare Limited

ISIN : INE910C01018
NSE : TTKHLTCARE
BSE : 507747
Face Value : 10
Industry : Pharmaceuticals & Drugs

EPS : 44.47
EPS (TTM) : 56.58
Price to Earning (P/E) : 26.76
Book Value : 705.23
Price to Bookvalue (P/B) : 1.69
Dividend Yield : 1 %
Return on Equity (ROE) : 6.46 %
Return on Capital Employed (ROCE) : 8.72 %

TTK Healthcare share price (02-Apr-2026)
National Stock Exchange NSE
Open / Close	0 - 0 NAN %
Low / High	0 - 0 NAN %
Trade Volume	0
52 Week Low / High	0 - 0 NAN %
Bombay Stock Exchange BSE
Open / Close	795 - 783.8 -1.4 %
Low / High	764.9 - 795 3.9 %
Trade Volume	150
52 Week Low / High	737 - 1402 90.2 %

YOU MAY ALSO LIKE

CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
How much money do you need to retire
Know how much money do you need to retire, before how much to invest ?
Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE
Share Market basics for beginners
Share Market jargons in simple terms
High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE
Stock market course tutorial
Stock Market Investment Course explained in simple words.

Consolidated Standalone

CONSOLIDATED QUARTERLY RESULT FOR TTK HEALTHCARE LIMITED

Date End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	1926.2	1697.92	1825.61	1801.37	2021.24	1857.67	1838.47	1810.56	2079.02	1984.87
Total Income	2024.83	1808.55	1943.54	1957.51	2167.37	2017.97	1997.52	1971.15	2249.28	2161.9
Total Expenditure	1888.6	1658.02	1741.37	1649.62	1920.82	1762.32	1785.12	1686.39	2009.95	1902.59
Other Income	98.62	110.63	117.93	156.13	146.13	160.3	159.05	160.58	170.26	177.03
Operating Profit	136.23	150.53	202.17	307.89	246.55	255.65	212.4	284.76	239.33	259.31
Interest	27.09	7.96	7.8	9.53	8.6	7.31	2.35	9.3	8.58	7.38
Exceptional Items									197.7
PBDT	109.14	142.57	194.37	298.36	237.95	248.34	210.05	275.46	428.45	251.93
Depreciation	31.98	33.21	32.09	30.79	31.56	32.78	33.05	33.2	20.51	20.05
Profit Before Tax	77.16	109.36	162.28	267.57	206.39	215.56	177	242.26	407.94	231.88
Tax	33.77	30.22	42.33	63.36	49.69	55.49	48.05	59.54	92.19	59.87
Profit After Tax	43.39	79.14	119.95	204.21	156.7	160.07	128.95	182.72	315.75	172.01
Net Profit	6008.61	99.14	119.95	169.44	156.7	160.07	128.95	182.72	315.75	172.01
Equity Capital	141.3	141.3	141.3	141.3	141.3	141.3	141.3	141.3	141.3	141.3
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	3.07	5.6	8.49	14.45	11.09	11.33	9.13	12.93	22.35	12.17
Diluted Eps After Extraordinary Items	3.07	5.6	8.49	14.45	11.09	11.33	9.13	12.93	22.35	12.17
Diluted Eps Before Extraordinary Items	3.07	5.6	8.49	14.45	11.09	11.33	9.13	12.93	22.35	12.17

STANDALONE QUARTERLY RESULT FOR TTK HEALTHCARE LIMITED

Date End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	1926.2	1697.92	1825.61	1801.37	2021.24	1857.67	1838.47	1810.56	2079.02	1984.87
Total Income	2024.83	1808.55	1943.54	1957.51	2167.37	2017.97	1997.52	1971.15	2249.28	2161.9
Total Expenditure	1888.6	1658.02	1741.37	1649.62	1920.82	1762.32	1785.12	1686.39	2009.95	1902.59
Other Income	98.62	110.63	117.93	156.13	146.13	160.3	159.05	160.58	170.26	177.03
Operating Profit	136.23	150.53	202.17	307.89	246.55	255.65	212.4	284.76	239.33	259.31
Interest	27.09	7.96	7.8	9.53	8.6	7.31	2.35	9.3	8.58	7.38
Exceptional Items									197.7
PBDT	109.14	142.57	194.37	298.36	237.95	248.34	210.05	275.46	428.45	251.93
Depreciation	31.98	33.21	32.09	30.79	31.56	32.78	33.05	33.2	20.51	20.05
Profit Before Tax	77.16	109.36	162.28	267.57	206.39	215.56	177	242.26	407.94	231.88
Tax	33.77	30.22	42.33	63.36	49.69	55.49	48.05	59.54	92.19	59.87
Profit After Tax	43.39	79.14	119.95	204.21	156.7	160.07	128.95	182.72	315.75	172.01
Net Profit	6008.61	99.14	119.95	169.44	156.7	160.07	128.95	182.72	315.75	172.01
Equity Capital	141.3	141.3	141.3	141.3	141.3	141.3	141.3	141.3	141.3	141.3
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Calculated EPS	3.07	5.6	8.49	14.45	11.09	11.33	9.13	12.93	22.35	12.17
Diluted Eps After Extraordinary Items	3.07	5.6	8.49	14.45	11.09	11.33	9.13	12.93	22.35	12.17
Diluted Eps Before Extraordinary Items	3.07	5.6	8.49	14.45	11.09	11.33	9.13	12.93	22.35	12.17

Consolidated Standalone

CONSOLIDATED ANNUAL RESULT FOR TTK HEALTHCARE LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	5992.4	7251.1	7527.94
Total Income	6155.71	7734.42	8154.01
Total Expenditure	5774.02	6937.6	7154.67
Other Income	163.31	483.32	626.07
Operating Profit	381.69	796.82	999.34
Interest	32.38	52.39	27.56
Exceptional Items	24.9
PBDT	374.21	744.43	971.78
Depreciation	125.84	128.06	130.59
Profit Before Tax	248.37	616.37	841.19
Tax	63.27	169.67	212.78
Profit After Tax	185.1	446.7	628.41
Net Profit	415.88	6397.15	628.41
Equity Capital	141.3	141.3	141.3
Face Value (IN RS)	10	10	10
Reserves	3110.87	9348.4	9823.74
Calculated EPS	13.1	31.61	44.47
Diluted Eps After Extraordinary Items	13.1	31.61	44.47
Diluted Eps Before Extraordinary Items	13.1	31.61	44.47

STANDALONE ANNUAL RESULT FOR TTK HEALTHCARE LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	5992.4	7251.1	7527.94
Total Income	6155.71	7734.42	8154.01
Total Expenditure	5774.02	6937.6	7154.67
Other Income	163.31	483.32	626.07
Operating Profit	381.69	796.82	999.34
Interest	32.38	52.39	27.56
Exceptional Items	24.9
PBDT	374.21	744.43	971.78
Depreciation	125.84	128.06	130.59
Profit Before Tax	248.37	616.37	841.19
Tax	63.27	169.67	212.78
Profit After Tax	185.1	446.7	628.41
Net Profit	415.88	6397.15	628.41
Equity Capital	141.3	141.3	141.3
Face Value (IN RS)	10	10	10
Reserves	3110.87	9348.4	9823.74
Calculated EPS	13.1	31.61	44.47
Diluted Eps After Extraordinary Items	13.1	31.61	44.47
Diluted Eps Before Extraordinary Items	13.1	31.61	44.47

Consolidated Standalone

CONSOLIDATED PROFIT / LOSS FOR TTK HEALTHCARE LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	636.53 Cr	599.24 Cr	725.11 Cr	791.2 Cr
Sales	633.42 Cr	596.07 Cr	720.19 Cr	786.05 Cr
Net Sales	636.53 Cr	599.24 Cr	725.11 Cr	752.79 Cr
Increase/Decrease in Stock	4.05 Cr	-12.37 Cr	-4.72 Cr	-10.6 Cr
Raw Material Consumed	247.68 Cr	293.87 Cr	352.49 Cr	348.85 Cr
Opening Raw Materials	11.27 Cr	13.59 Cr	16.18 Cr	17.36 Cr
Purchases Raw Materials	101.46 Cr	146.05 Cr	183.47 Cr	175 Cr
Closing Raw Materials	13.81 Cr	16.18 Cr	17.36 Cr	19.1 Cr
Other Direct Purchases / Brought in cost	148.77 Cr	150.4 Cr	170.21 Cr	175.59 Cr
Power & Fuel Cost	13.99 Cr	15.83 Cr	19.84 Cr	21.79 Cr
Electricity & Power	13.99 Cr	15.83 Cr	19.84 Cr	21.79 Cr
Employee Cost	160.08 Cr	102.84 Cr	123.38 Cr	132.84 Cr
Salaries, Wages & Bonus	139.26 Cr	88.54 Cr	113.67 Cr	118.38 Cr
Contributions to EPF & Pension Funds	8.28 Cr	6.91 Cr	5.29 Cr	5.6 Cr
Workmen and Staff Welfare Expenses	4.71 Cr	3.88 Cr	4.87 Cr	5.83 Cr
Other Manufacturing Expenses	17.78 Cr	18.79 Cr	19.74 Cr	22.15 Cr
Processing Charges	54 Lk	61.97 Lk	67.63 Lk	98.72 Lk
Repairs and Maintenance	12.33 Cr	9.71 Cr	15.19 Cr	17.75 Cr
General and Administration Expenses	45.46 Cr	37.35 Cr	44.44 Cr	49.94 Cr
Rent , Rates & Taxes	3.29 Cr	3.44 Cr	3.13 Cr	3.61 Cr
Insurance	92.39 Lk	82.18 Lk	1.02 Cr	1.17 Cr
Printing and stationery	1.11 Cr	90.89 Lk	1.22 Cr	1.31 Cr
Professional and legal fees	5.5 Cr	7.77 Cr	7.89 Cr	10.39 Cr
Traveling and conveyance	20.97 Cr	14 Cr	18.9 Cr	20.52 Cr
Selling and Distribution Expenses	104.74 Cr	115.03 Cr	130.53 Cr	141.55 Cr
Advertisement & Sales Promotion	78.93 Cr	89.31 Cr	101.24 Cr	113.17 Cr
Freight and Forwarding	25.8 Cr	25.72 Cr	29.29 Cr	28.39 Cr
Miscellaneous Expenses	7.86 Cr	6.08 Cr	8.06 Cr	8.94 Cr
Bad debts /advances written off	27.59 Lk	18.39 Lk	40.99 Lk	56.73 Lk
Provision for doubtful debts	1.12 Cr	28.8 Lk	1.03 Lk	0
Loss on disposal of fixed assets(net)	11.93 Lk	1.56 Lk	13.83 Lk	3.33 Lk
Total Expenditure	601.64 Cr	577.4 Cr	693.76 Cr	715.47 Cr
Other Income	10 Cr	16.33 Cr	48.33 Cr	62.61 Cr
Interest Received	9.87 Cr	14.66 Cr	46.31 Cr	62.11 Cr
Dividend Received	7.13 Lk	9.8 Lk	6.39 Lk	10.81 Lk
Foreign Exchange Gains	3.41 Lk	31.17 Lk	56.24 Lk	25.65 Lk
Operating Profit	44.89 Cr	38.17 Cr	79.68 Cr	99.93 Cr
Interest	2.22 Cr	3.24 Cr	5.24 Cr	2.76 Cr
Bank Charges etc	12 Lk	0	0	0
PBDT	42.67 Cr	34.93 Cr	74.44 Cr	97.18 Cr
Depreciation	13.71 Cr	12.58 Cr	12.81 Cr	13.06 Cr
Profit Before Taxation & Exceptional Items	28.95 Cr	22.35 Cr	61.64 Cr	84.12 Cr
Exceptional Income / Expenses	8.1 Cr	2.49 Cr	0	0
Profit Before Tax	37.05 Cr	24.84 Cr	61.64 Cr	84.12 Cr
Provision for Tax	-9.39 Cr	6.33 Cr	16.97 Cr	21.28 Cr
Current Income Tax	12.25 Cr	7.44 Cr	17.41 Cr	22.1 Cr
Deferred Tax	-1.99 Cr	-1.11 Cr	-44.26 Lk	-82.16 Lk
Profit After Tax	46.44 Cr	18.51 Cr	44.67 Cr	62.84 Cr
Extra items	0	0	595.04 Cr	0
Consolidated Net Profit	46.44 Cr	18.51 Cr	639.71 Cr	62.84 Cr
Profit Balance B/F	126.45 Cr	167.71 Cr	200.94 Cr	826.77 Cr
Appropriations	172.89 Cr	186.22 Cr	840.66 Cr	889.62 Cr
Other Appropriation	5.18 Cr	-14.72 Cr	13.88 Cr	14.99 Cr
Equity Dividend %	60	100	100	100
Earnings Per Share	32.87	13.1	31.61	44.47
Adjusted EPS	32.87	13.1	31.61	44.47

STANDALONE PROFIT / LOSS FOR TTK HEALTHCARE LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	636.53 Cr	599.24 Cr	725.11 Cr	791.2 Cr
Sales	633.42 Cr	596.07 Cr	720.19 Cr	786.05 Cr
Net Sales	636.53 Cr	599.24 Cr	725.11 Cr	752.79 Cr
Increase/Decrease in Stock	4.05 Cr	-12.37 Cr	-4.72 Cr	-10.6 Cr
Raw Material Consumed	247.68 Cr	293.87 Cr	352.49 Cr	348.85 Cr
Opening Raw Materials	11.27 Cr	13.59 Cr	16.18 Cr	17.36 Cr
Purchases Raw Materials	101.46 Cr	146.05 Cr	183.47 Cr	175 Cr
Closing Raw Materials	13.81 Cr	16.18 Cr	17.36 Cr	19.1 Cr
Other Direct Purchases / Brought in cost	148.77 Cr	150.4 Cr	170.21 Cr	175.59 Cr
Power & Fuel Cost	13.99 Cr	15.83 Cr	19.84 Cr	21.79 Cr
Electricity & Power	13.99 Cr	15.83 Cr	19.84 Cr	21.79 Cr
Employee Cost	160.08 Cr	102.84 Cr	123.38 Cr	132.84 Cr
Salaries, Wages & Bonus	139.26 Cr	88.54 Cr	113.67 Cr	118.38 Cr
Contributions to EPF & Pension Funds	8.28 Cr	6.91 Cr	5.29 Cr	5.6 Cr
Workmen and Staff Welfare Expenses	4.71 Cr	3.88 Cr	4.87 Cr	5.83 Cr
Other Manufacturing Expenses	17.78 Cr	18.79 Cr	19.74 Cr	22.15 Cr
Processing Charges	54 Lk	61.97 Lk	67.63 Lk	98.72 Lk
Repairs and Maintenance	12.33 Cr	9.71 Cr	15.19 Cr	17.75 Cr
General and Administration Expenses	45.46 Cr	37.35 Cr	44.44 Cr	49.94 Cr
Rent , Rates & Taxes	3.29 Cr	3.44 Cr	3.13 Cr	3.61 Cr
Insurance	92.39 Lk	82.18 Lk	1.02 Cr	1.17 Cr
Printing and stationery	1.11 Cr	90.89 Lk	1.22 Cr	1.31 Cr
Professional and legal fees	5.5 Cr	7.77 Cr	7.89 Cr	10.39 Cr
Traveling and conveyance	20.97 Cr	14 Cr	18.9 Cr	20.52 Cr
Selling and Distribution Expenses	104.74 Cr	115.03 Cr	130.53 Cr	141.55 Cr
Advertisement & Sales Promotion	78.93 Cr	89.31 Cr	101.24 Cr	113.17 Cr
Freight and Forwarding	25.8 Cr	25.72 Cr	29.29 Cr	28.39 Cr
Miscellaneous Expenses	7.86 Cr	6.08 Cr	8.06 Cr	8.94 Cr
Bad debts /advances written off	27.59 Lk	18.39 Lk	40.99 Lk	56.73 Lk
Provision for doubtful debts	1.12 Cr	28.8 Lk	1.03 Lk	0
Loss on disposal of fixed assets(net)	11.93 Lk	1.56 Lk	13.83 Lk	3.33 Lk
Total Expenditure	601.64 Cr	577.4 Cr	693.76 Cr	715.47 Cr
Other Income	10 Cr	16.33 Cr	48.33 Cr	62.61 Cr
Interest Received	9.87 Cr	14.66 Cr	46.31 Cr	62.11 Cr
Dividend Received	7.13 Lk	9.8 Lk	6.39 Lk	10.81 Lk
Foreign Exchange Gains	3.41 Lk	31.17 Lk	56.24 Lk	25.65 Lk
Operating Profit	44.89 Cr	38.17 Cr	79.68 Cr	99.93 Cr
Interest	2.22 Cr	3.24 Cr	5.24 Cr	2.76 Cr
Bank Charges etc	12 Lk	0	0	0
PBDT	42.67 Cr	34.93 Cr	74.44 Cr	97.18 Cr
Depreciation	13.71 Cr	12.58 Cr	12.81 Cr	13.06 Cr
Profit Before Taxation & Exceptional Items	28.95 Cr	22.35 Cr	61.64 Cr	84.12 Cr
Exceptional Income / Expenses	8.1 Cr	2.49 Cr	0	0
Profit Before Tax	37.05 Cr	24.84 Cr	61.64 Cr	84.12 Cr
Provision for Tax	-9.39 Cr	6.33 Cr	16.97 Cr	21.28 Cr
Current Income Tax	12.25 Cr	7.44 Cr	17.41 Cr	22.1 Cr
Deferred Tax	-1.99 Cr	-1.11 Cr	-44.26 Lk	-82.16 Lk
Profit After Tax	46.44 Cr	18.51 Cr	44.67 Cr	62.84 Cr
Extra items	0	0	595.04 Cr	0
Consolidated Net Profit	46.44 Cr	18.51 Cr	639.71 Cr	62.84 Cr
Profit Balance B/F	126.45 Cr	167.71 Cr	200.94 Cr	826.77 Cr
Appropriations	172.89 Cr	186.22 Cr	840.66 Cr	889.62 Cr
Other Appropriation	5.18 Cr	-14.72 Cr	13.88 Cr	14.99 Cr
Equity Dividend %	60	100	100	100
Earnings Per Share	32.87	13.1	31.61	44.47
Adjusted EPS	32.87	13.1	31.61	44.47

Consolidated Standalone

CONSOLIDATED CASH FLOW FOR TTK HEALTHCARE LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	37.05 Cr	57.78 Cr	838.08 Cr	84.12 Cr
Adjustment	-2.14 Cr	25.76 Lk	-803.09 Cr	-48.77 Cr
Changes In working Capital	41.19 Cr	-3.86 Cr	-43.9 Cr	-15.33 Cr
Cash Flow after changes in Working Capital	76.1 Cr	54.18 Cr	-8.91 Cr	20.01 Cr
Cash Flow from Operating Activities	96.42 Cr	45 Cr	-24.81 Cr	-4.94 Cr
Cash Flow from Investing Activities	-77.24 Cr	-30.55 Cr	31.69 Cr	28.49 Cr
Cash Flow from Financing Activitie	-17.16 Cr	-9.14 Cr	-12.43 Cr	-21.91 Cr
Net Cash Inflow / Outflow	2.03 Cr	5.31 Cr	-5.54 Cr	1.64 Cr
Opening Cash & Cash Equivalents	7.53 Cr	9.55 Cr	14.86 Cr	9.32 Cr
Closing Cash & Cash Equivalent	9.55 Cr	14.86 Cr	9.32 Cr	10.96 Cr

STANDALONE CASH FLOW FOR TTK HEALTHCARE LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	37.05 Cr	57.78 Cr	838.08 Cr	84.12 Cr
Adjustment	-2.14 Cr	25.76 Lk	-803.09 Cr	-48.77 Cr
Changes In working Capital	41.19 Cr	-3.86 Cr	-43.9 Cr	-15.33 Cr
Cash Flow after changes in Working Capital	76.1 Cr	54.18 Cr	-8.91 Cr	20.01 Cr
Cash Flow from Operating Activities	96.42 Cr	45 Cr	-24.81 Cr	-4.94 Cr
Cash Flow from Investing Activities	-77.24 Cr	-30.55 Cr	31.69 Cr	28.49 Cr
Cash Flow from Financing Activitie	-17.16 Cr	-9.14 Cr	-12.43 Cr	-21.91 Cr
Net Cash Inflow / Outflow	2.03 Cr	5.31 Cr	-5.54 Cr	1.64 Cr
Opening Cash & Cash Equivalents	7.53 Cr	9.55 Cr	14.86 Cr	9.32 Cr
Closing Cash & Cash Equivalent	9.55 Cr	14.86 Cr	9.32 Cr	10.96 Cr

Consolidated Standalone

CONSOLIDATED BALANCE SHEET FOR TTK HEALTHCARE LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	14.13 Cr	14.13 Cr	14.13 Cr	14.13 Cr
Equity - Authorised	20 Cr	20 Cr	20 Cr	20 Cr
Equity - Issued	14.13 Cr	14.13 Cr	14.13 Cr	14.13 Cr
Equity Paid Up	14.13 Cr	14.13 Cr	14.13 Cr	14.13 Cr
Face Value	10	10	10	10
Total Reserves	280.52 Cr	315.5 Cr	939.25 Cr	986.79 Cr
Securities Premium	9.82 Cr	9.82 Cr	9.82 Cr	9.82 Cr
Capital Reserves	6.81 Cr	6.81 Cr	6.81 Cr	6.81 Cr
Profit & Loss Account Balance	167.71 Cr	200.94 Cr	826.77 Cr	874.63 Cr
General Reserves	78.48 Cr	78.48 Cr	78.48 Cr	78.48 Cr
Reserve excluding Revaluation Reserve	276.1 Cr	311.09 Cr	934.84 Cr	982.37 Cr
Revaluation reserve	4.41 Cr	4.41 Cr	4.41 Cr	4.41 Cr
Shareholder's Funds	294.65 Cr	329.63 Cr	953.38 Cr	1000.92 Cr
Deferred Tax Assets / Liabilities	-6.45 Cr	-7.3 Cr	-4.36 Cr	-5.44 Cr
Deferred Tax Assets	8.59 Cr	8.66 Cr	4.63 Cr	5.74 Cr
Deferred Tax Liability	2.14 Cr	1.35 Cr	27.28 Lk	29.98 Lk
Other Long Term Liabilities	2.96 Cr	3.23 Cr	2.92 Cr	79.87 Lk
Long Term Provisions	7.9 Cr	5.16 Cr	3.03 Cr	3.06 Cr
Total Non-Current Liabilities	4.41 Cr	1.08 Cr	1.59 Cr	-1.58 Cr
Trade Payables	97.61 Cr	103.46 Cr	124.46 Cr	102.26 Cr
Sundry Creditors	97.61 Cr	103.46 Cr	124.46 Cr	102.26 Cr
Other Current Liabilities	67.25 Cr	89.28 Cr	53.49 Cr	53.42 Cr
Advances received from customers	75.34 Lk	2.17 Cr	38.52 Lk	61.44 Lk
Short Term Borrowings	17.6 Cr	20.38 Cr	25.53 Cr	21.47 Cr
Secured ST Loans repayable on Demands	17.6 Cr	20.38 Cr	25.53 Cr	21.47 Cr
Working Capital Loans- Sec	17.6 Cr	20.38 Cr	25.53 Cr	21.47 Cr
Short Term Provisions	6.31 Cr	7.41 Cr	7.3 Cr	18.66 Cr
Provision for Tax	1.41 Cr	3.09 Cr	2.52 Cr	0
Provision for post retirement benefits	4.9 Cr	4.32 Cr	0	0
Total Current Liabilities	188.76 Cr	220.53 Cr	210.78 Cr	195.82 Cr
Total Liabilities	487.82 Cr	551.25 Cr	1165.75 Cr	1195.15 Cr
Gross Block	158.78 Cr	164.96 Cr	164.22 Cr	177.87 Cr
Less: Accumulated Depreciation	73.43 Cr	84.69 Cr	93.03 Cr	102.94 Cr
Less: Impairment of Assets	0	0	0	11.97 Lk
Net Block	85.35 Cr	80.27 Cr	71.19 Cr	74.81 Cr
Capital Work in Progress	44.5 Lk	18.67 Lk	2.79 Cr	79.02 Lk
Non Current Investments	13.17 Cr	15.13 Cr	12.85 Cr	12.56 Cr
Long Term Investment	13.17 Cr	15.13 Cr	12.85 Cr	12.56 Cr
Quoted	13.17 Cr	15.13 Cr	12.85 Cr	12.56 Cr
Long Term Loans & Advances	13.62 Cr	6.81 Cr	11.26 Cr	6.61 Cr
Other Non Current Assets	0	0	1.26 Cr	23.09 Cr
Total Non-Current Assets	112.57 Cr	102.41 Cr	99.35 Cr	117.85 Cr
Inventories	70.3 Cr	78.92 Cr	84.51 Cr	96.99 Cr
Raw Materials	13.81 Cr	16.18 Cr	17.36 Cr	19.1 Cr
Work-in Progress	7.3 Cr	7.99 Cr	15.82 Cr	21.05 Cr
Finished Goods	45.62 Cr	50.64 Cr	47.28 Cr	53.63 Cr
Stores and Spare	1.26 Cr	1.39 Cr	1.08 Cr	1.21 Cr
Sundry Debtors	59.78 Cr	53.58 Cr	92.1 Cr	86.44 Cr
Debtors more than Six months	0	2.82 Cr	3.55 Cr	2.18 Cr
Debtors Others	61.35 Cr	52.38 Cr	89.4 Cr	85.11 Cr
Cash and Bank	227.69 Cr	273.51 Cr	847.16 Cr	774.94 Cr
Cash in hand	11.46 Lk	9.39 Lk	6.45 Lk	6.41 Lk
Balances at Bank	227.58 Cr	273.41 Cr	847.1 Cr	774.88 Cr
Other Current Assets	6.67 Cr	31.82 Cr	27.46 Cr	31.25 Cr
Interest accrued on Investments	4.21 Cr	5.16 Cr	22.3 Cr	27.07 Cr
Prepaid Expenses	2.46 Cr	2.38 Cr	2.01 Cr	2.7 Cr
Short Term Loans and Advances	10.8 Cr	11.01 Cr	15.17 Cr	87.68 Cr
Advances recoverable in cash or in kind	6.2 Cr	4.92 Cr	5.88 Cr	4.05 Cr
Advance income tax and TDS	2.02 Cr	3.45 Cr	7.09 Cr	10.92 Cr
Total Current Assets	375.25 Cr	448.84 Cr	1066.4 Cr	1077.3 Cr
Net Current Assets (Including Current Investments)	186.48 Cr	228.3 Cr	855.62 Cr	881.48 Cr
Total Assets	487.82 Cr	551.25 Cr	1165.75 Cr	1195.15 Cr
Contingent Liabilities	14.48 Cr	26.1 Cr	26.93 Cr	14.37 Cr
Total Debt	17.6 Cr	20.38 Cr	25.53 Cr	21.47 Cr
Book Value	205.4	230.16	671.59	705.23
Adjusted Book Value	205.4	230.16	671.59	705.23

STANDALONE BALANCE SHEET FOR TTK HEALTHCARE LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	14.13 Cr	14.13 Cr	14.13 Cr	14.13 Cr
Equity - Authorised	20 Cr	20 Cr	20 Cr	20 Cr
Equity - Issued	14.13 Cr	14.13 Cr	14.13 Cr	14.13 Cr
Equity Paid Up	14.13 Cr	14.13 Cr	14.13 Cr	14.13 Cr
Face Value	10	10	10	10
Total Reserves	280.52 Cr	315.5 Cr	939.25 Cr	986.79 Cr
Securities Premium	9.82 Cr	9.82 Cr	9.82 Cr	9.82 Cr
Capital Reserves	6.81 Cr	6.81 Cr	6.81 Cr	6.81 Cr
Profit & Loss Account Balance	167.71 Cr	200.94 Cr	826.77 Cr	874.63 Cr
General Reserves	78.48 Cr	78.48 Cr	78.48 Cr	78.48 Cr
Reserve excluding Revaluation Reserve	276.1 Cr	311.09 Cr	934.84 Cr	982.37 Cr
Revaluation reserve	4.41 Cr	4.41 Cr	4.41 Cr	4.41 Cr
Shareholder's Funds	294.65 Cr	329.63 Cr	953.38 Cr	1000.92 Cr
Deferred Tax Assets / Liabilities	-6.45 Cr	-7.3 Cr	-4.36 Cr	-5.44 Cr
Deferred Tax Assets	8.59 Cr	8.66 Cr	4.63 Cr	5.74 Cr
Deferred Tax Liability	2.14 Cr	1.35 Cr	27.28 Lk	29.98 Lk
Other Long Term Liabilities	2.96 Cr	3.23 Cr	2.92 Cr	79.87 Lk
Long Term Provisions	7.9 Cr	5.16 Cr	3.03 Cr	3.06 Cr
Total Non-Current Liabilities	4.41 Cr	1.08 Cr	1.59 Cr	-1.58 Cr
Trade Payables	97.61 Cr	103.46 Cr	124.46 Cr	102.26 Cr
Sundry Creditors	97.61 Cr	103.46 Cr	124.46 Cr	102.26 Cr
Other Current Liabilities	67.25 Cr	89.28 Cr	53.49 Cr	53.42 Cr
Advances received from customers	75.34 Lk	2.17 Cr	38.52 Lk	61.44 Lk
Short Term Borrowings	17.6 Cr	20.38 Cr	25.53 Cr	21.47 Cr
Secured ST Loans repayable on Demands	17.6 Cr	20.38 Cr	25.53 Cr	21.47 Cr
Working Capital Loans- Sec	17.6 Cr	20.38 Cr	25.53 Cr	21.47 Cr
Short Term Provisions	6.31 Cr	7.41 Cr	7.3 Cr	18.66 Cr
Provision for Tax	1.41 Cr	3.09 Cr	2.52 Cr	0
Provision for post retirement benefits	4.9 Cr	4.32 Cr	0	0
Total Current Liabilities	188.76 Cr	220.53 Cr	210.78 Cr	195.82 Cr
Total Liabilities	487.82 Cr	551.25 Cr	1165.75 Cr	1195.15 Cr
Gross Block	158.78 Cr	164.96 Cr	164.22 Cr	177.87 Cr
Less: Accumulated Depreciation	73.43 Cr	84.69 Cr	93.03 Cr	102.94 Cr
Less: Impairment of Assets	0	0	0	11.97 Lk
Net Block	85.35 Cr	80.27 Cr	71.19 Cr	74.81 Cr
Capital Work in Progress	44.5 Lk	18.67 Lk	2.79 Cr	79.02 Lk
Non Current Investments	13.17 Cr	15.13 Cr	12.85 Cr	12.56 Cr
Long Term Investment	13.17 Cr	15.13 Cr	12.85 Cr	12.56 Cr
Quoted	13.17 Cr	15.13 Cr	12.85 Cr	12.56 Cr
Long Term Loans & Advances	13.62 Cr	6.81 Cr	11.26 Cr	6.61 Cr
Other Non Current Assets	0	0	1.26 Cr	23.09 Cr
Total Non-Current Assets	112.57 Cr	102.41 Cr	99.35 Cr	117.85 Cr
Inventories	70.3 Cr	78.92 Cr	84.51 Cr	96.99 Cr
Raw Materials	13.81 Cr	16.18 Cr	17.36 Cr	19.1 Cr
Work-in Progress	7.3 Cr	7.99 Cr	15.82 Cr	21.05 Cr
Finished Goods	45.62 Cr	50.64 Cr	47.28 Cr	53.63 Cr
Stores and Spare	1.26 Cr	1.39 Cr	1.08 Cr	1.21 Cr
Sundry Debtors	59.78 Cr	53.58 Cr	92.1 Cr	86.44 Cr
Debtors more than Six months	0	2.82 Cr	3.55 Cr	2.18 Cr
Debtors Others	61.35 Cr	52.38 Cr	89.4 Cr	85.11 Cr
Cash and Bank	227.69 Cr	273.51 Cr	847.16 Cr	774.94 Cr
Cash in hand	11.46 Lk	9.39 Lk	6.45 Lk	6.41 Lk
Balances at Bank	227.58 Cr	273.41 Cr	847.1 Cr	774.88 Cr
Other Current Assets	6.67 Cr	31.82 Cr	27.46 Cr	31.25 Cr
Interest accrued on Investments	4.21 Cr	5.16 Cr	22.3 Cr	27.07 Cr
Prepaid Expenses	2.46 Cr	2.38 Cr	2.01 Cr	2.7 Cr
Short Term Loans and Advances	10.8 Cr	11.01 Cr	15.17 Cr	87.68 Cr
Advances recoverable in cash or in kind	6.2 Cr	4.92 Cr	5.88 Cr	4.05 Cr
Advance income tax and TDS	2.02 Cr	3.45 Cr	7.09 Cr	10.92 Cr
Total Current Assets	375.25 Cr	448.84 Cr	1066.4 Cr	1077.3 Cr
Net Current Assets (Including Current Investments)	186.48 Cr	228.3 Cr	855.62 Cr	881.48 Cr
Total Assets	487.82 Cr	551.25 Cr	1165.75 Cr	1195.15 Cr
Contingent Liabilities	14.48 Cr	26.1 Cr	26.93 Cr	14.37 Cr
Total Debt	17.6 Cr	20.38 Cr	25.53 Cr	21.47 Cr
Book Value	205.4	230.16	671.59	705.23
Adjusted Book Value	205.4	230.16	671.59	705.23

Consolidated Standalone

FINANCIAL RATIOS (CONSOLIDATED) FOR TTK HEALTHCARE LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	32.87	13.1	31.61	44.47
CEPS(Rs)	42.57	22.01	40.67	53.71
DPS(Rs)	6	10	10	10
Book NAV/Share(Rs)	205.4	230.16	671.59	705.23
Tax Rate(%)	-25.34	25.47	27.53	25.3
Margin Ratios
Core EBITDA Margin(%)	5.48	3.64	4.32	4.72
EBIT Margin(%)	6.17	4.69	9.22	10.98
Pre Tax Margin(%)	5.82	4.14	8.5	10.63
PAT Margin (%)	7.3	3.09	6.16	7.94
Cash Profit Margin (%)	9.45	5.19	7.93	9.59
Performance Ratios
ROA(%)	10.15	3.56	5.2	5.32
ROE(%)	17.37	6.02	7.01	6.46
ROCE(%)	13.53	8.59	10.13	8.72
Asset Turnover(x)	1.39	1.15	0.84	0.67
Sales/Fixed Asset(x)	4.14	3.7	4.41	4.63
Working Capital/Sales(x)	3.41	2.62	0.85	0.9
Efficiency Ratios
Fixed Capital/Sales(x)	0.24	0.27	0.23	0.22
Receivable days	39.15	34.52	36.67	41.18
Inventory Days	40.7	45.45	41.14	41.87
Payable days	59.93	130.35	119.6	114.99
Valuation Parameters
PER(x)	15.05	63.29	32.71	33.35
PCE(x)	11.62	37.68	25.42	27.61
Price/Book(x)	2.41	3.6	1.54	2.1
Yield(%)	1.21	1.21	0.97	0.67
EV/Net Sales(x)	0.77	1.53	0.88	1.78
EV/Core EBITDA(x)	10.89	24.06	8.03	13.43
EV/EBIT(x)	12.45	32.71	9.56	15.45
EV/CE(x)	1	1.67	0.55	1.32
M Cap / Sales	1.1	1.96	2.01	2.78
Growth Ratio
Net Sales Growth(%)	-1.43	25.88	21.01	3.82
Core EBITDA Growth(%)	21.09	30.47	108.76	25.42
EBIT Growth(%)	73.07	15.38	138.2	29.91
PAT Growth(%)	276.98	-49.68	141.32	40.69
EPS Growth(%)	276.98	-49.68	141.32	40.69
Financial Stability Ratios
Total Debt/Equity(x)	0.06	0.06	0.03	0.02
Current Ratio(x)	1.99	2.04	5.06	5.5
Quick Ratio(x)	1.62	1.68	4.66	5.01
Interest Cover(x)	17.66	8.67	12.77	31.53
Total Debt/Mcap(x)	0.03	0.02	0.02	0.01

FINANCIAL RATIOS (STANDALONE) FOR TTK HEALTHCARE LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	32.87	13.1	31.61	44.47
CEPS(Rs)	42.57	22.01	40.67	53.71
DPS(Rs)	6	10	10	10
Book NAV/Share(Rs)	205.4	230.16	671.59	705.23
Tax Rate(%)	-25.34	25.47	27.53	25.3
Margin Ratios
Core EBITDA Margin(%)	5.48	3.64	4.32	4.72
EBIT Margin(%)	6.17	4.69	9.22	10.98
Pre Tax Margin(%)	5.82	4.14	8.5	10.63
PAT Margin (%)	7.3	3.09	6.16	7.94
Cash Profit Margin (%)	9.45	5.19	7.93	9.59
Performance Ratios
ROA(%)	10.15	3.56	5.2	5.32
ROE(%)	17.37	6.02	7.01	6.46
ROCE(%)	13.53	8.59	10.13	8.72
Asset Turnover(x)	1.39	1.15	0.84	0.67
Sales/Fixed Asset(x)	4.14	3.7	4.41	4.63
Working Capital/Sales(x)	3.41	2.62	0.85	0.9
Efficiency Ratios
Fixed Capital/Sales(x)	0.24	0.27	0.23	0.22
Receivable days	39.15	34.52	36.67	41.18
Inventory Days	40.7	45.45	41.14	41.87
Payable days	59.93	130.35	119.6	114.99
Valuation Parameters
PER(x)	15.05	63.29	32.71	33.35
PCE(x)	11.62	37.68	25.42	27.61
Price/Book(x)	2.41	3.6	1.54	2.1
Yield(%)	1.21	1.21	0.97	0.67
EV/Net Sales(x)	0.77	1.53	0.88	1.78
EV/Core EBITDA(x)	10.89	24.06	8.03	13.43
EV/EBIT(x)	12.45	32.71	9.56	15.45
EV/CE(x)	1	1.67	0.55	1.32
M Cap / Sales	1.1	1.96	2.01	2.78
Growth Ratio
Net Sales Growth(%)	-1.43	25.88	21.01	3.82
Core EBITDA Growth(%)	21.09	30.47	108.76	25.42
EBIT Growth(%)	73.07	15.38	138.2	29.91
PAT Growth(%)	276.98	-49.68	141.32	40.69
EPS Growth(%)	276.98	-49.68	141.32	40.69
Financial Stability Ratios
Total Debt/Equity(x)	0.06	0.06	0.03	0.02
Current Ratio(x)	1.99	2.04	5.06	5.5
Quick Ratio(x)	1.62	1.68	4.66	5.01
Interest Cover(x)	17.66	8.67	12.77	31.53
Total Debt/Mcap(x)	0.03	0.02	0.02	0.01

SHARE HOLDING PATTERN FOR TTK HEALTHCARE LIMITED

Date	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters %	74.56	74.56	74.56	74.56	74.56	74.56	74.56	74.56	74.56	74.56
FII %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
DII %	0.00	0.00	0.00	0.00	1.13	1.14	1.13	1.13	1.13	1.13
Public %	20.59	20.85	20.94	20.07	19.77	20.36	20.45	22.45	22.43	22.40

PEER COMPARISON FOR TTK HEALTHCARE LIMITED

No.	Name
1	AMBALAL SARABHAI ENTERPRISES LTD
2	Cipla Limited
3	Dr. Reddy's Laboratories Limited
4	Procter & Gamble Health Limited
5	J.K.PHARMACHEM LTD
6	Lupin Limited
7	Lyka Labs Limited
8	MESCO PHARMACEUTICALS LTD
9	Morepen Laboratories Limited
10	Piramal Enterprises Limited
11	Torrent Pharmaceuticals Limited
12	Abbott India Limited
13	GlaxoSmithKline Pharmaceuticals Limited
14	Sanofi India Limited
15	Pfizer Limited
16	Bliss GVS Pharma Limited
17	Alembic Limited
18	Unichem Laboratories Limited
19	AstraZeneca Pharma India Limited
20	GUJARAT THEMIS BIOSYN LTD
21	JB Chemicals & Pharmaceuticals Limited
22	TTK Healthcare Limited
23	Jagsonpal Pharmaceuticals Limited
24	Gufic Biosciences Limited
25	Sequent Scientific Limited
26	Albert David Limited
27	IOL Chemicals and Pharmaceuticals Limited
28	Wanbury Limited
29	Kopran Limited
30	Aarti Drugs Limited
31	Orchid Pharma Limited
32	Biofil Chemicals & Pharmaceuticals Limited
33	Marksans Pharma Limited
34	IPCA Laboratories Limited
35	Kilitch Drugs (India) Limited
36	Krebs Biochemicals and Industries Limited
37	Neuland Laboratories Limited
38	Ind-Swift Limited
39	Hester Biosciences Limited
40	Parenteral Drugs (India) Limited
41	Sun Pharmaceutical Industries Limited
42	Hikal Limited
43	Caplin Point Laboratories Limited
44	Aurobindo Pharma Limited
45	Natco Pharma Limited
46	Bal Pharma Limited
47	BDH INDUSTRIES LTD
48	Venus Remedies Limited
49	Jubilant Pharmova Limited
50	Themis Medicare Limited

CORPORATE ACTIONS FOR TTK HEALTHCARE

Exchange Date	Purpose	Book Closure Dates
BSE 14-Oct-2024	Board Meeting - Quarterly Results	25-Oct-2024
BSE 10-Jul-2024	Board Meeting - Quarterly Results	02-Aug-2024
BSE 28-Jun-2024	Book Closure - Rs.10.0000 per share(100%)Final Dividend & A.G.M.	18-Jul-2024 24-Jul-2024
BSE 28-Jun-2024	AGM - Rs.10.0000 per share(100%)Final Dividend & A.G.M.	24-Jul-2024 24-Jul-2024
BSE 24-May-2024	Dividend - Rs.10.0000 per share(100%)Final Dividend
BSE 02-May-2024	Board Meeting - Final Dividend & Audited Results	24-May-2024
BSE 02-Jan-2024	Board Meeting - Quarterly Results	02-Feb-2024
BSE 04-Oct-2023	Board Meeting - Quarterly Results	03-Nov-2023
BSE 14-Jul-2023	Board Meeting - Quarterly Results	01-Aug-2023
BSE 13-Jul-2023	Delist - Announcement under Regulation 28 of the SEBI (Delisting of Equity Shares) Regulations, 2021
BSE 30-Jun-2023	Book Closure - Rs.10.0000 per share(100%)Final Dividend & A.G.M.	19-Jul-2023 25-Jul-2023
BSE 30-Jun-2023	AGM - Rs.10.0000 per share(100%)Final Dividend & A.G.M.	25-Jul-2023 25-Jul-2023
BSE 23-May-2023	Dividend - Rs.10.0000 per share(100%)Final Dividend
BSE 02-May-2023	Board Meeting - Audited Results & Final Dividend	23-May-2023
BSE 20-Apr-2023	Delist - Voluntary Delisting of Shares Inter alia, took the following decisions:- (a) The Due Diligence Report dated 20rh April, 2023 ("Report") submitted by M/s A K Jain & Associates, Practicing Company Secrelaries, a Peer Review Company Secrelary Firm, in terms of Regulation '10(3) of SEBI Delisting Regulations, was reviewed and taken on record by the Board. (b) Further, the Audit Report dated 20th April...	20-Apr-2023
BSE 06-Apr-2023	Delist - Voluntary Delisting of Shares	20-Apr-2023
BSE 06-Apr-2023	Board Meeting - Voluntary Delisting of Shares	20-Apr-2023
BSE 27-Dec-2022	Board Meeting - Quarterly Results	07-Feb-2023
BSE 14-Oct-2022	Board Meeting - Quarterly Results	28-Oct-2022
BSE 11-Jul-2022	Board Meeting - Quarterly Results	26-Jul-2022
BSE 27-Jun-2022	Book Closure - Rs.10.0000 per share(100%)Final Dividend & A.G.M.	28-Jul-2022 03-Aug-2022
BSE 23-May-2022	AGM - Inter alia, approved: (i) Dividend of Rs.10/- (100%) per Equity Share of Rs.10/- each, forthe financial year ended 31st March, 2022 which shall be paid i despatched within 21 days from the date of AGM, subject to the approval of the Shareholders: (ii) The 64th Annual General Meeting of the Company has been scheduled to be held on Wednesday, the 3rd August, 2022, through Video Conferencing / Other ...	03-Aug-2022
BSE 23-May-2022	Dividend - Rs.10.0000 per share(100%)Final Dividend
BSE 02-May-2022	Board Meeting - Final Dividend & Audited Results	23-May-2022
BSE 12-Jan-2022	Board Meeting - Quarterly Results	09-Feb-2022
BSE 27-Sep-2021	Board Meeting - Quarterly Results	29-Oct-2021

CORPORATE ANNOUNCEMENTS FOR TTK HEALTHCARE

Exchange Date	Category File	Description
BSE 26-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Announcement under Reg 30 (LODR) - Newspaper Publication
BSE 25-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Compliance under Reg 39(3) of SEBI (LODR) Regulations 2015 - Loss of Share Certificates
BSE 25-Oct-2024	General Announcements FILE	Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Outcome of the Board Meeting - Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 25-Oct-2024	Outcome FILE	Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Outcome of the Board Meeting - Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 25-Oct-2024	Outcome FILE	Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Unaudited Financial Results along with the Limited Review Report for the Second Quarter and Half-Year ended September 30 2024
BSE 23-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Compliance under Reg 39(3) of SEBI (LODR) Regulations 2015 - Loss of Share Certificates
BSE 22-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Compliance under Reg 39(3) of SEBI(LODR) Regulations 2015 - Loss of Share Certificates
BSE 19-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Announcement under Regulation 30 (LODR) - Newspaper Publication
BSE 18-Oct-2024	Intimation FILE	Shareholder Meeting / Postal Ballot-Notice of Postal Ballot Postal Ballot Notice dated October 16 2024
BSE 16-Oct-2024	General Announcements FILE	Outcome Of The Board Meeting Held On October 16 2024 Outcome of the Board Meeting held on October 16 2024
BSE 16-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Management Outcome of the Board Meeting held on October 16 2024
BSE 16-Oct-2024	Outcome FILE	Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Outcome of the Board Meeting - Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 14-Oct-2024	Intimation FILE	Board Meeting Intimation for Board Meeting Intimation - October 25 2024 TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve Board Meeting Intimation - October 25 2024
BSE 14-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Certificate under Reg 39(3) of SEBI (LODR) Regulations 2015 - Loss of Share Certificates
BSE 07-Oct-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Reg 74(5) of SEBI(DP) Regulations 2018 - September 30 2024
BSE 04-Oct-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Compliance under Reg 39(3) of SEBI(LODR) Regulations 2015 - Loss of Share Certificates
BSE 27-Sep-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Certificate under Reg 39(3) of SEBI (LODR) Regulations 2015 - Loss of Share Certificate
BSE 25-Sep-2024	Intimation FILE	Closure of Trading Window Closure of Trading Window - Unaudited Financial Results for the Quarter and half-year ending September 30 2024
BSE 13-Sep-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Reg 39(3) of SEBI (LODR) Reg 2015 - Loss of Share Certificate
BSE 27-Aug-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Reg 39(3) of SEBI(LODR) Reg 2015 - Loss of Share Certificate
BSE 21-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Directorate Completion of tenure of Independent Directors
BSE 21-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Management Completion of tenure of Independent Directors
BSE 21-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Cessation Completion of tenure of Independent Directors
BSE 03-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Newspaper Publication Publication of Unaudited Financial Results in Business Standard and Makkal Kural
BSE 02-Aug-2024	General Announcements FILE	Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Outcome of the Board Meeting - Disclosure under Regulations 30 of SEBI (LODR) Regulations 2015
BSE 02-Aug-2024	Outcome FILE	Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Outcome of the Board Meeting - Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015
BSE 02-Aug-2024	Outcome FILE	Unaudited Financial Results Along With Limited Review Report For The First Quarter Ended June 30 2024 Unaudited Financial Results along with Limited Review Report for the First Quarter ended June 30 2024
BSE 25-Jul-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Reg 39(3) of SEBI (LODR) Regulations 2015 - Loss of Share Certificate
BSE 24-Jul-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report Voting Results as per Reg 44 of SEBI (LODR) Regulations 2015
BSE 24-Jul-2024	General Announcements FILE	Chairman'S Speech - 66Th Annual General Meeting Of The Company - July 24 2024 Chairmans Speech - 66th Annual General Meeting of the Company - July 24 2024

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
No Insider trading details found

BULK BLOCK DEALS FOR TTK HEALTHCARE LIMITED

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 24-Mar-2023	Buy BULK	131,788 @ 911.08	ABAKKUS ASSET MANAGER LLP
BSE 24-Mar-2023	Buy BULK	115,385 @ 910.00	ABAKKUS DIVERSIFIED ALPHA FUND
BSE 24-Mar-2023	Sell BULK	245,873 @ 910.00	MCAP INDIA FUND LIMITED
BSE 24-Mar-2023	Buy BLOCK	130,488 @ 910.00	ABAKKUS ASSET MANAGER LLP
BSE 24-Mar-2023	Buy BLOCK	115,385 @ 910.00	ABAKKUS DIVERSIFIED ALPHA FUND
BSE 24-Mar-2023	Sell BLOCK	115,385 @ 910.00	MCAP INDIA FUND LIMITED
BSE 24-Mar-2023	Sell BLOCK	130,488 @ 910.00	MCAP INDIA FUND LIMITED

DIVIDEND BY TTK HEALTHCARE LIMITED

Ex Dividend Date	Dividend Type	Dividend
16-Jul-2024	DIVIDEND	10
18-Jul-2023	DIVIDEND	10
26-Jul-2022	DIVIDEND	10
12-Aug-2021	DIVIDEND	6

SPLIT / BONUS BY TTK HEALTHCARE LIMITED

No Split / Bonus details found

Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed

Facebook

Twitter

To TOP

TTK Healthcare Limited

TTK Healthcare share price

CONSOLIDATED QUARTERLY RESULT FOR TTK HEALTHCARE LIMITED

STANDALONE QUARTERLY RESULT FOR TTK HEALTHCARE LIMITED

CONSOLIDATED ANNUAL RESULT FOR TTK HEALTHCARE LIMITED

STANDALONE ANNUAL RESULT FOR TTK HEALTHCARE LIMITED

CONSOLIDATED PROFIT / LOSS FOR TTK HEALTHCARE LIMITED

STANDALONE PROFIT / LOSS FOR TTK HEALTHCARE LIMITED

CONSOLIDATED CASH FLOW FOR TTK HEALTHCARE LIMITED

STANDALONE CASH FLOW FOR TTK HEALTHCARE LIMITED

CONSOLIDATED BALANCE SHEET FOR TTK HEALTHCARE LIMITED

STANDALONE BALANCE SHEET FOR TTK HEALTHCARE LIMITED

FINANCIAL RATIOS (CONSOLIDATED) FOR TTK HEALTHCARE LIMITED

FINANCIAL RATIOS (STANDALONE) FOR TTK HEALTHCARE LIMITED

SHARE HOLDING PATTERN FOR TTK HEALTHCARE LIMITED

PEER COMPARISON FOR TTK HEALTHCARE LIMITED

CORPORATE ACTIONS FOR TTK HEALTHCARE

CORPORATE ANNOUNCEMENTS FOR TTK HEALTHCARE

INSIDER TRADING FOR TTK HEALTHCARE

BULK BLOCK DEALS FOR TTK HEALTHCARE LIMITED

DIVIDEND BY TTK HEALTHCARE LIMITED

SPLIT / BONUS BY TTK HEALTHCARE LIMITED